Influenza C virus susceptibility to antivirals with different mechanisms of action
- 2 May 2024
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 68 (5) , e0172723
Abstract
Antiviral susceptibility of influenza viruses was assessed using a high-content imaging-based neutralization test. Cap-dependent endonuclease inhibitors, baloxavir and AV5116, were superior to AV5115 against type A viruses, and AV5116 was most effective against PA mutants tested. However, these three inhibitors displayed comparable activity (EC 50 8–22 nM) against type C viruses from six lineages. Banana lectin and a monoclonal antibody, YA3, targeting the hemagglutinin-esterase protein effectively neutralized some, but not all, type C viruses.Keywords
This publication has 19 references indexed in Scilit:
- Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses isolated from birds and mammals in the United States, 2022Antiviral Research, 2023
- Influenza antivirals and their role in pandemic preparednessAntiviral Research, 2022
- An optimized cell-based assay to assess influenza virus replication by measuring neuraminidase activity and its applications for virological surveillanceAntiviral Research, 2022
- Synthesis, inhibitory activity and oral dosing formulation of AV5124, the structural analogue of influenza virus endonuclease inhibitor baloxavirJournal of Antimicrobial Chemotherapy, 2021
- A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivoProceedings of the National Academy of Sciences of the United States of America, 2020
- Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018Scientific Reports, 2019
- Favipiravir as a potential countermeasure against neglected and emerging RNA virusesAntiviral Research, 2018
- Engineering a Therapeutic Lectin by Uncoupling Mitogenicity from Antiviral ActivityCell, 2015
- Inhibition of influenza virus replication by phosphorothioate oligodeoxynucleotides.Proceedings of the National Academy of Sciences, 1990
- Comparative activities of several nucleoside analogs against influenza A, B, and C viruses in vitroAntimicrobial Agents and Chemotherapy, 1988